Therapeutic Artificial Organs for the Prevention of Aging Process
スポンサーリンク
概要
- 論文の詳細を見る
In 1983, the concept of therapeutic artificial organs was proposed by this author; it has already been more than 10 years since then. Currently developments of various types of immunomodulation technologies are well established and therapeutic artificial organs for the treatment of autoimmune diseases have become a well-accepted concept. It is this author's opinion, if we utilize apheresis technologies properly, we should be able to slow the aging process of mankind. Physical youth, and perhaps mental youth, can be achieved by apheresis technologies. However, to maintain a total youth and enjoy a high quality of life, it is essential to maintain a strong will to live. In this paper, a new type of an artificial organ is proposed. This anti-aging artifcial organ is named "Juzo"-the organ for a long life -in Japanese by this author.
- 日本アフェレシス学会の論文
- 1995-04-30
著者
-
Nose Yukihiko
Department Of Artificial Organs The Cleveland Clinic Foundation
-
Nose Yukihiko
Department of Surgery,Baylor College of Medicine
関連論文
- -354- LACTATE THRESHOLD FOR THE EVALUATION OF VARIOUS TOTAL ARTIFICIAL HEART (TAH) CONTROL MODES
- Development of a New Silicone Membrane Oxygenator for ECMO
- Control System for an Implantable Rotary Blood Pump
- Current Status of The Baylor Artificial Heart
- Assessment of the Total Artificial Heart (TAH) Pulsatility : The Coalition between Pulsatility and Ejection Time in TAH In Vitro Study
- Therapeutic Artificial Organs for the Prevention of Aging Process
- Development of Cardiac Prostheses in Japan
- BALANCING (YIN-YANG) HYPOTHESIS FOR ASSESSMENT OF EFFECTIVE APHERESIS THERAPIES
- Development of the oxygenator : past, present, and future
- Physiological Effects of Modified Hemoglobin As an Oxygen-carrying Macromolecule
- Studies on the Energy Metabolism of Erythrocytes during Artificial Heart Pumping
- A Case Report of 17 Days Survival with an Implanted Artificial Heart in a Calf
- Clinical Evaluation and the Appropriate Treatment for DFPP in Familial Hypercholesterolemia (FH)(LDL-Apheresis)